A federal court complaint alleges sex discrimination at the U.S. subsidiary of German pharmaceutical company Bayer, according to Bloomberg.
On April 2, Bloomberg reports, a judge denied Bayer’s request to bar the case from being considered for a class-action lawsuit.
The lawsuit was filed under the U.S. Equal Pay Act, and mentions disparities in pay and promotion opportunities compared with men in similar positions. It claims that “disregard and indifference for concerns or complaints about discrimination and sexual harassment pervades every corner of the company.”
Bayer is also facing thousands of lawsuits from plaintiffs who claim they’ve suffered from blood clots, pulmonary embolism, and stroke brought on by Yaz, Beyaz, Yasmin, Ocella, and other birth control pills containing the synthetic hormones drospirenone.
A number of studies show that Beyaz and the other contraceptives with drospirenone cause a significantly higher risk of blood clots, and the plaintiffs allege that Bayer failed to adequately warn them of the risks.
If you or a loved one has suffered injury as a result of taking any of these pills, contact Lopez McHugh for a free case evaluation.
See the report here: https://www.bloomberg.com/news/2012-04-02/bayer-loses-bid-to-bar-class-action-in-sex-bias-lawsuit-1-.html
